Activation requirements for the induction of CD4+CD25+ T cell suppressor function

被引:250
|
作者
Thornton, AM [1 ]
Piccirillo, CA [1 ]
Shevach, EM [1 ]
机构
[1] NIAID, LI, NIH, Bethesda, MD 20892 USA
关键词
T lymphocyte; tolerance; suppression; anergy; IL-2; receptor; cytokines; costimulation;
D O I
10.1002/eji.200324455
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The in vivo differentiation/survival of CD4(+)CD25(+) T suppressor cells is dependent on IL-2 and CD28-mediated costimulatory signals. To determine the cytokine and costimulatory requirements for CD25(+) T cells in vitro, we established a two-stage culture system where CD25(+) T cells were activated in a primary culture. In the subsequent culture, activated CD4(+)CD25(+) cells were then mixed with responders in order to assess their suppressor function. Pre-culture of CD25(+) T cells with anti-CD3 alone resulted in poor survival and minimal induction of suppressor activity. Pre-culture in the presence of anti-CD3 and IL-2 or IL-4, but not IL-6, IL-7, IL-9, IL-10 or IL-15, resulted in proliferation of the CD25(+) cells and induction of potent suppressor function. Inhibition of the interaction of CD28 or cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) with CD80/CD86 in the pre-culture of CD4(+)CD25(+) cells did not prevent the induction of suppressor function. Furthermore, the inhibition of costimulatory signals did not inhibit the ability of fresh CD25(+) T cells to inhibit CD8(+) responders under conditions where activation of the responders was independent of CD80/ CD86. These studies support the view that activation of CD25(+) T cells requires IL-2/IL-4 for their survival/differentiation into effector cells, but is independent of CD28/CTLA-4-mediated costimulation.
引用
收藏
页码:366 / 376
页数:11
相关论文
共 50 条
  • [41] Percentage and function of CD4+CD25+ regulatory T cells in patients with hyperthyroidism
    Jiang, Ting-Jun
    Cao, Xue-Liang
    Luan, Sha
    Cui, Wan-Hui
    Qiu, Si-Huang
    Wang, Yi-Chao
    Zhao, Chang-Jiu
    Fu, Peng
    MOLECULAR MEDICINE REPORTS, 2018, 17 (02) : 2137 - 2144
  • [42] Distinct robes of CTLA-4 and TGF-β in CD4+CD25+ regulatory T cell function
    Tang, QZ
    Boden, EK
    Henriksen, KJ
    Bour-Jordan, H
    Bi, MY
    Bluestone, JA
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (11) : 2996 - 3005
  • [43] Distribution and function of CD4+CD25+ regulatory T cells in murine schistosomiasis
    Baumgart, M
    Tompkins, F
    Hesse, M
    FASEB JOURNAL, 2005, 19 (04): : A935 - A935
  • [44] Development and function of naturally occurring CD4+CD25+ regulatory T cells
    Toda, Akiko
    Piccirillo, Ciriaco A.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2006, 80 (03) : 458 - 470
  • [45] A type 1 diabetes-associated CD25 haplotype affects CD4+CD25+ regulatory T cell function
    Tyler, J.
    Garg, G.
    Pekalski, M.
    Nutland, S.
    Peakman, M.
    Todd, J.
    Wicker, L.
    Tree, T.
    IMMUNOLOGY, 2011, 135 : 192 - 192
  • [46] CD4+CD25+ regulatory/suppressor T cells prevent allogeneic fetus rejection in mice
    Darasse-Jèze, G
    Klatzmann, D
    Charlotte, F
    Salomon, BL
    Cohen, JL
    IMMUNOLOGY LETTERS, 2006, 102 (01) : 106 - 109
  • [47] Induction and maintenance of self tolerance: the role of CD4+CD25+ regulatory T cells
    Kamalesh K. Bala
    Kamal D. Moudgil
    Archivum Immunologiae et Therapiae Experimentalis, 2006, 54 : 307 - 321
  • [48] Hepatocellular carcinoma cell supernatants increase expansion and function of CD4+CD25+ regulatory T cells
    Cao, Mengde
    Cabrera, Roniel
    Xu, Yiling
    Firpi, Roberto
    Zhu, Haizhen
    Liu, Chen
    Nelson, David R.
    LABORATORY INVESTIGATION, 2007, 87 (06) : 582 - 590
  • [49] Induction and maintenance of self tolerance:: the role of CD4+CD25+ regulatory T cells
    Bala, Kamalesh K.
    Moudgil, Kamal D.
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2006, 54 (05) : 307 - 321
  • [50] Circulating CD4+CD25+ and CD4+CD25- T cells in myasthenia gravis
    Huang, Y
    Pirskanen, R
    Ciscombe, R
    Link, H
    Lefvert, AK
    MYASTHENIA GRAVIS AND RELATED DISORDERS: BIOMCHEMICAL BASIS FOR DISEASE OF THE NEUROMUSCULAR JUNCTION, 2003, 998 : 318 - 319